Skip to main content

Table 3 Bias risk assessment according to the cochrane collaboration

From: Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials

Components assessed

DUTCH PEERS [17]

HOST-ASSURE [18]

Lin2015 [15]

Mehilli 2013 [16]

RESOLUTE [19]

TWENTE [20]

1

2

2

2

2

2

2

2

2

2

1

2

2

2

3

1

1

1

1

2

1

4

2

1

1

1

2

2

5

1

1

1

1

1

1

6

1

1

1

1

1

1

Total score

9

8

7

8

10

9

Bias grade

B

B

C

B

A

B

  1. The six components recommended by the Cochrane Collaborations to assess bias risk
  2. 1: Sequence generation
  3. 2: Allocation sequence concealment
  4. 3: Blinding of participants and personnel
  5. 4: Blinding of outcome assessment
  6. 5: Incomplete outcome data
  7. 6: Selective outcome reporting and other potential bias